Clinical Trials Browser

Terminated × Bevacizumab × 90 days × Clear all

NCT05733611 2026-02-02

RP2/RP3 in Combination With Atezolizumab and Bevacizumab for the Treatment of Patients With CRC

Phase 2 Terminated

Gastrointestinal

Colorectal Neoplasms

NCT06332079 2026-01-05

HAITI

Phase 2 Terminated

Gastrointestinal

Colorectal Cancer Metastatic